课题基金 / 基金详情

DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES

生物防御和新发传染病候选疫苗的开发

批准号：

10888431

负责人：

EMILY VOIGT

金额：

$123.67万

依托单位：

ACCESS TO ADVANCED HEALTH INSTITUTE

依托单位国家：

美国

项目类别：

财政年份：

2023

资助国家：

美国

项目状态：

已结题

起止时间：

2023-07-05 至 2024-11-04

来源：

https://reporter.nih.gov/project-details/10888431

关键词：

Advanced Development Animal Model Chikungunya virus Clinical Communicable Diseases Contracts Disease Outbreaks Emerging Communicable Diseases Formulation Individual Safety Toxicology Vaccines biodefense efficacy evaluation efficacy testing immunogenicity manufacture response stability testing vaccine candidate vaccine development

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文